PTC
SUPN icon

Petrus Trust Company’s Supernus Pharmaceuticals SUPN Stock Holding History

Petrus Trust Company’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-8,362
Closed -$242K – 779
2023
Q4 		$242K Hold
8,362
– – 0.02% 514
2023
Q3 		$231K Hold
8,362
– – 0.02% 487
2023
Q2 		$251K Buy
+8,362
New +$293K 0.03% 455
2020
Q3 		– Sell
-11,876
Closed -$282K – 361
2020
Q2 		$282K Buy
+11,876
New +$262K 0.03% 92
2019
Q3 		– Sell
-6,217
Closed -$206K – 346
2019
Q2 		$206K Sell
6,217
-3,729
-37% -$128K 0.04% 225
2019
Q1 		$349K Buy
9,946
+2,572
+35% +$95.7K 0.07% 82
2018
Q4 		$245K Buy
+7,374
New +$317K 0.05% 134
2018
Q3 		– Sell
-4,966
Closed -$297K – 328
2018
Q2 		$297K Sell
4,966
-5,376
-52% -$278K 0.06% 128
2018
Q1 		$474K Buy
10,342
+4,630
+81% +$193K 0.11% 59
2017
Q4 		$228K Buy
+5,712
New +$226K 0.06% 133
2017
Q3 		– Sell
-6,470
Closed -$279K – 214
2017
Q2 		$279K Sell
6,470
-7,160
-53% -$255K 0.06% 118
2017
Q1 		$427K Buy
13,630
+1,823
+15% +$48.9K 0.1% 71
2016
Q4 		$298K Sell
11,807
-3,949
-25% -$88.2K 0.07% 95
2016
Q3 		$390K Buy
15,756
+4,099
+35% +$92.8K 0.09% 66
2016
Q2 		$237K Buy
+11,657
New +$207K 0.05% 106

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Petrus Trust Company's SUPN Position: Q1 2024 in Review

Petrus Trust Company sold out of Supernus Pharmaceuticals (SUPN) in Q1 2024, closing a stake of 8,362 shares — an estimated $242K sold.

Petrus Trust Company first reported a position in SUPN in Q2 2016 and held it in 15 quarters. The position peaked at $474K in Q1 2018. 250 funds tracked by Wall St. Rank hold SUPN as of Q1 2024.

  • Petrus Trust Company reported no remaining Supernus Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Petrus Trust Company sold 8,362 Supernus Pharmaceuticals shares in Q1 2024, an estimated $242K.
  • Petrus Trust Company first reported a position in Supernus Pharmaceuticals in Q2 2016 and held it in 15 quarters.
  • Petrus Trust Company's Supernus Pharmaceuticals position peaked at $474K in Q1 2018.
  • 250 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q1 2024.

Based on Petrus Trust Company's 13F filing for Q1 2024, filed 15 May 2024.